Search - tctmd.com

Displaying 1 - 20 of 22

Sort: Relevancy | Date

News Conference News

Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices

L.A. McKeown

November 18, 2022

Presentation TCT 2022

Safety and Performance of a Sirolimus Eluting Resorbable Coronary Magnesium Scaffold (DREAMS 3G): The BIOMAG-1 FIH Trial

Presenter: Michael Haude

September 19, 2022

Presentation TCT 2022

TCT 155: The Bioadaptor RCT Study: Comparison of a Novel Sirolimus-Eluting Bioadaptor with Zotarolimus-Eluting Stent in de novo Coronary Arteries

Presenter: Holger Nef

September 19, 2022

Presentation TCT 2022

TCT 139: Long Term Clinical Outcomes of a Novel Sirolimus Coated Balloon in Coronary Intervention:Data From Real World Population

Presenter: Sampath Athukorala

September 18, 2022

Presentation TCT 2022

TCT 138: Clinical Outcomes Following use of Sirolimus Coated Balloon in Side-branch During Provisional Stent Technique in True Bifurcations

Presenter: Sampath Athukorala

September 18, 2022

Presentation TCT 2022

TCT 136: Use Of Sirolimus Coated Balloon in De Novo Small Vessel Coronary Lesions in Acute Coronary Syndrome; Long-Term Follow-Up From A Single Centre Registry

Presenter: Waseem Raja

September 18, 2022

Presentation TCT 2022

The Future of Sirolimus Coated Balloons: a look at the design of IDE clinical trials

Presenter: Azeem Latib

September 18, 2022

Presentation TCT 2022

Sirolimus Coated Balloon in real life complex settings: Case Presentations with long term FU and positive remodelling

Presenter: Sandeep Basavarajaiah

September 18, 2022

Presentation TCT 2022

Sirolimus-coated balloon: from EASTBOURNE, the Largest DCB study ever, to the next step, TRANSFORM 2 RCT

Presenter: Bernardo Cortese

September 18, 2022

Presentation TCT 2022

DCB in CAD: understanding the existing and new indications

Presenter: Antonio Colombo

September 18, 2022

Presentation TCT 2022

Sirolimus Coated Balloon with Nanolute Technology: Pre-clinical Insights and Rationale

Presenter: Aloke Finn

September 18, 2022

Presentation TCT 2022

Introduction & Session Objectives

Presenter: Martin Leon

September 18, 2022

Presentation TCT 2022

TCT 64: FANTOM II Long Lesion Study: Initial Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold in Long Lesions – 3 Clinical Year Outcomes

Presenter: Matthias Lutz

September 17, 2022

Presentation TCT 2022

TCT 58: FANTOM II Trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – Final: 5 Year Clinical Outcomes

Presenter: Matthias Lutz

September 17, 2022

Presentation TCT 2022

Sirolimus DCBs: Technological Trends, Challenges and Advantages

Presenter: Ron Waksman

September 17, 2022

Presentation TCT 2022

Sirolimus Coated DCB in All-Comers EASTBOURNE (MagicTouch DCB)

Presenter: Bernardo Cortese

September 17, 2022

News Industry News

TRANSFORM 1 Enrollment Completed: A Crucial RCT ready to redefine the DCB Angioplasty Mechanism

September 13, 2022

Podcast TCTMD Talking Points

Two DCBs Go Head to Head in De Novo CAD

August 24, 2022

News Conference News EuroPCR 2022

Shorter DAPT Sufficient Even in Complex HBR Patients: MASTER DAPT

Yael L. Maxwell

May 17, 2022

JSousa1.cropped (002) in memoriam_header

News Daily News

Stent Pioneer José Eduardo Sousa Dies, Age 88

Shelley Wood

March 14, 2022

Advertisement

Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices

Safety and Performance of a Sirolimus Eluting Resorbable Coronary Magnesium Scaffold (DREAMS 3G): The BIOMAG-1 FIH Trial

TCT 155: The Bioadaptor RCT Study: Comparison of a Novel Sirolimus-Eluting Bioadaptor with Zotarolimus-Eluting Stent in de novo Coronary Arteries

TCT 139: Long Term Clinical Outcomes of a Novel Sirolimus Coated Balloon in Coronary Intervention:Data From Real World Population

TCT 138: Clinical Outcomes Following use of Sirolimus Coated Balloon in Side-branch During Provisional Stent Technique in True Bifurcations

TCT 136: Use Of Sirolimus Coated Balloon in De Novo Small Vessel Coronary Lesions in Acute Coronary Syndrome; Long-Term Follow-Up From A Single Centre Registry

The Future of Sirolimus Coated Balloons: a look at the design of IDE clinical trials

Sirolimus Coated Balloon in real life complex settings: Case Presentations with long term FU and positive remodelling

Sirolimus-coated balloon: from EASTBOURNE, the Largest DCB study ever, to the next step, TRANSFORM 2 RCT

DCB in CAD: understanding the existing and new indications

Sirolimus Coated Balloon with Nanolute Technology: Pre-clinical Insights and Rationale

Introduction & Session Objectives

TCT 64: FANTOM II Long Lesion Study: Initial Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold in Long Lesions – 3 Clinical Year Outcomes

TCT 58: FANTOM II Trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – Final: 5 Year Clinical Outcomes

Sirolimus DCBs: Technological Trends, Challenges and Advantages

Sirolimus Coated DCB in All-Comers EASTBOURNE (MagicTouch DCB)

TRANSFORM 1 Enrollment Completed: A Crucial RCT ready to redefine the DCB Angioplasty Mechanism

Two DCBs Go Head to Head in De Novo CAD

Shorter DAPT Sufficient Even in Complex HBR Patients: MASTER DAPT

Stent Pioneer José Eduardo Sousa Dies, Age 88

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content